Gynocyte® - a Bio-Nucleonics Market Exclusive

Bio-Nucleonics’ patented Gynocyte® device is the Healthcare Industry’s leading edge tool in combating cervical and other gynecological cancers...
Read more >>

Welcome to Bio-Nucleonics, Inc.

Bio-Nucleonics, is the only U.S. Company focused on the development and production of generic radiopharmaceuticals. It is approved by the U.S. Food and Drug Administration (FDA), the U.S. Nuclear Regulatory Commission, and the Florida Board of Pharmacy. The Company is experienced in the manufacturing of products in accordance with current Good Manufacturing Practice (cGMP) and Good Laboratory Practice (cGLP).

Bio-Nucleonics is dedicated to improving the patient’s quality of life. We achieve this by developing and producing state-of-the-art radiopharmaceuticals...

Learn more >>

Our Products

Generic Strontium Chloride Sr-89 injection, USP Generic Strontium Chloride Sr-89 Generic Strontium Chloride Sr-89 Injection (Generic Metastron®) is an option to consider for cancer bone pain therapy. Generic Strontium Chloride Sr-89 Injection imitates the...
Lean more >>

Gynocyte® a BioNucleonics Market Exclusive Gynocyte®
Bio-Nucleonics received FDA marketing clearance for Gynocyte®, a minimally invasive medical device that helps doctors deliver life-saving treatment to patients with...
Learn more >>